The DOI matches its Crossref record; 36 of the 39 references it cites were found in a registry or an index.
Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study
Open accessAbstract
BACKGROUND: The COVID-19 pandemic and efforts to reduce SARS-CoV-2 transmission substantially affected health services worldwide. To better understand the impact of the pandemic on childhood routine immunisation, we estimated disruptions in vaccine coverage associated with the pandemic in 2020, globally and by Global Burden of Disease (GBD) super-region. METHODS: For this analysis we used a two-step hierarchical random spline modelling approach to estimate global and regional disruptions to routine immunisation using administrative data and reports from electronic immunisation systems, with mobility data as a model input. Paired with estimates of vaccine coverage expected in the absence of COVID-19, which were derived from vaccine coverage models from GBD 2020, Release 1 (GBD 2020 R1), we estimated the number of children who missed routinely delivered doses of the third-dose diphtheria-tetanus-pertussis (DTP3) vaccine and first-dose measles-containing vaccine (MCV1) in 2020. FINDINGS: Globally, in 2020, estimated vaccine coverage was 76·7% (95% uncertainty interval 74·3-78·6) for DTP3 and 78·9% (74·8-81·9) for MCV1, representing relative reductions of 7·7% (6·0-10·1) for DTP3 and 7·9% (5·2-11·7) for MCV1, compared to expected doses delivered in the absence of the COVID-19 pandemic. From January to December, 2020, we estimated that 30·0 million (27·6-33·1) children missed doses of DTP3 and 27·2 million (23·4-32·5) children missed MCV1 doses. Compared to expected gaps in coverage for eligible children in 2020, these estimates represented an additional 8·5 million (6·5-11·6) children not routinely vaccinated with DTP3 and an additional 8·9 million (5·7-13·7) children not routinely vaccinated with MCV1 attributable to the COVID-19 pandemic. Globally, monthly disruptions were highest in April, 2020, across all GBD super-regions, with 4·6 million (4·0-5·4) children missing doses of DTP3 and 4·4 million (3·7-5·2) children missing doses of MCV1. Every GBD super-region saw reductions in vaccine coverage in March and April, with the most severe annual impacts in north Africa and the Middle East, south Asia, and Latin America and the Caribbean. We estimated the lowest annual reductions in vaccine delivery in sub-Saharan Africa, where disruptions remained minimal throughout the year. For some super-regions, including southeast Asia, east Asia, and Oceania for both DTP3 and MCV1, the high-income super-region for DTP3, and south Asia for MCV1, estimates suggest that monthly doses were delivered at or above expected levels during the second half of 2020. INTERPRETATION: Routine immunisation services faced stark challenges in 2020, with the COVID-19 pandemic causing the most widespread and largest global disruption in recent history. Although the latest coverage trajectories point towards recovery in some regions, a combination of lagging catch-up immunisation services, continued SARS-CoV-2 transmission, and persistent gaps in vaccine coverage before the pandemic still left millions of children under-vaccinated or unvaccinated against preventable diseases at the end of 2020, and these gaps are likely to extend throughout 2021. Strengthening routine immunisation data systems and efforts to target resources and outreach will be essential to minimise the risk of vaccine-preventable disease outbreaks, reach children who missed routine vaccine doses during the pandemic, and accelerate progress towards higher and more equitable vaccination coverage over the next decade. FUNDING: Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a previous analysis using partial-year data from the first months of the pandemic, Causey and colleagues estimated 2020 global DTP3 coverage at approximately 76.7%, which is 7.7 pp lower than was expected in the absence of the pandemic.18”
In the citing paper
“The COVID-19 pandemic has disrupted routine health services globally, resulting in decreased vaccination rates affecting millions of children [8]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, H., Abbas, K. M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abolhassani, H., Abreu, L. G., Abrigo, M. R. M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30977-6 · Cited by 1,971 · cited 2×
“…C , and the estimated monthly number of eligible children calculated from GBD 2020 R1 annual target population estimates (updated from GBD 2019 36 as part of the GBD continuous update cycle), pop m : 1000 draws of N were calculated from draws of MDR and C to incorporate uncertainty in both…”
Self-citationGuidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30388-9 · Cited by 1,798 · cited 1×
“This analysis complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) statement, 17 with further information provided in the appendix (section 1); all source codes used to generate estimates and corres ponding data will be made accessible upon publication, on…”
Fullman, N., Yearwood, J., Abay, S. M., Abbafati, C., Abd-Allah, F., Abdela, J., Abdelalim, A., Abebe, Z., Abebo, T. A., Aboyans, V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30994-2 · Cited by 1,013 · cited 1×
“Other covariates were considered in addition to our mobility measure (eg, total COVID-19 deaths and cases to date, indices of development, 36 and health-system performance 37 ), but they provided no meaningful associations with disruptions to vaccine coverage.”
Self-citationMobile phone data for informing public health actions across the COVID-19 pandemic life cycle
Oliver, N., Lepri, B., Sterly, H., Lambiotte, R., Deletaille, S., De Nadai, M., Letouzé, E., Salah, A. A., Benjamins, R., Cattuto, C., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc0764 · Cited by 631 · cited 1×
“30 Full methodological details about generating mobility estimates have been published elsewhere, 31 but in brief, we synthesised daily human movement data obtained from mobile phones from Descartes Labs, 32 Facebook, 33 Google, 34 and SafeGraph 35 in 134 countries and territories into cohesive…”
Modeling COVID-19 scenarios for the United States
IHME COVID-19 Forecasting Team, Reiner, R. C., Barber, R. M., Collins, J. K., Zheng, P., Adolph, C., Albright, J., Antony, C. M., Aravkin, A. Y., Bachmeier, S. D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1132-9 · Cited by 556
Self-citationStatistical Meta‐Analysis with Applications
Hartung, J., Knapp, G., & Sinha, B. K. (2008) · Wiley Series in Probability and Statistics · doi:10.1002/9780470386347 · Cited by 418 · cited 1×
“27 We used qualitative data collected by WHO and partners, including two sets of Pulse poll results, 4,28 essential health services polls, 7 and additional data from WHO regional offices, to evaluate estimated CDRs.”
Abbas, K., Procter, S. R., van Zandvoort, K., Clark, A., Funk, S., Mengistu, T., Hogan, D., Dansereau, E., Jit, M., Flasche, S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30308-9 · Cited by 362 · cited 1×
“As evidenced by past epidemics and modelling exercises, 45,46 substantive gaps in vaccine coverage increase the risk of vaccine-preventable disease outbreaks once COVID-19 prevention measures subside and individuals resume pre-pandemic social contact patterns.”
McDonald, H. I., Tessier, E., White, J. M., Woodruff, M., Knowles, C., Bates, C., Parry, J., Walker, J. L., Scott, J. A., Smeeth, L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.19.2000848 · Cited by 337
Statistical meta-analysis with applications
(2009) · Choice Reviews Online · doi:10.5860/choice.46-4497 · Cited by 311
Turner, N. (2009) · PubMed · Cited by 306
Research works printed but not linked: 2
- Daley, 2020, Vaccinations have sharply declined nationwide during the COVID-19 pandemic, Scientific American
- Akhter, 2020, Pakistan resumes polio vaccinations after coronavirus hiatus, AlJazeera
Cited by
Naghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasian, M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00367-2 · Cited by 2,889
“51 55 Our study also found that some vaccine-preventable diseases, such as measles, have shown widespread reductions in mortality rates and were geographically concen trated.”
BackgroundWang, H., Paulson, K. R., Pease, S. A., Watson, S., Comfort, H., Zheng, P., Aravkin, A. Y., Bisignano, C., Barber, R. M., Alam, T., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02796-3 · Cited by 2,069
“Many mechanisms have been proposed, including reduced vaccination rates 26 and reduced births in hospitals.”
Self-citationBender, R. G., Sirota, S. B., Swetschinski, L. R., Dominguez, R.-M. V., Novotney, A., Wool, E. E., Ikuta, K. S., Vongpradith, A., Rogowski, E. L. B., Doxey, M., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00176-2 · Cited by 596
Self-citationCOVID-19 and resilience of healthcare systems in ten countries
Arsenault, C., Gage, A., Kim, M. K., Kapoor, N. R., Akweongo, P., Amponsah, F., Aryal, A., Asai, D., Awoonor-Williams, J. K., Ayele, W., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01750-1 · Cited by 554
Bardosh, K., de Figueiredo, A., Gur-Arie, R., Jamrozik, E., Doidge, J., Lemmens, T., Keshavjee, S., Graham, J. E., & Baral, S. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-008684 · Cited by 318
Metadata
- Authors
- Causey, K., Fullman, N., Sorensen, R. J. D., Galles, N. C., Zheng, P., Aravkin, A., Danovaro-Holliday, M. C., Martinez-Piedra, R., Sodha, S. V., Velandia-González, M. P., Gacic-Dobo, M., Castro, E., He, J., Schipp, M., Deen, A., Hay, S. I., Lim, S. S., & Mosser, J. F.
- Affiliations
- University of Washington (US)
- World Health Organization Regional Office for the Americas (US)
- Seattle Children's Hospital (US)
- Corresponding author
- Mosser, Jonathan F
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 398
- Issue
- 10299
- Pages
- 522-534
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC8285122
- OpenAlex
- W3183723118
- Cited by
- 450
- References
- 39
- Citations by year
- 2026: 58 · 2025: 61 · 2024: 79 · 2023: 123 · 2022: 103 · 2021: 25
- FWCI
- 45.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/3.0/igo/ (vor)
- Locations
- The Lancet (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Bill and Melinda Gates Foundation
- World Health Organization
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Keywords
- COVID-19 pandemic, childhood immunization, measles-containing vaccine, missed vaccine doses, mobility data, vaccine hesitancy, healthcare disruption, child health outcomes
- MeSH terms
- Vaccination Coverage, COVID-19, Child, Humans, Measles Vaccine, Global Health, Models, Statistical, Diphtheria-Tetanus-Pertussis Vaccine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. https://app.cochat.ai/papers/10.1016/s0140-6736(21)01337-4
- The paper
- Causey, K., Fullman, N., Sorensen, R. J. D., Galles, N. C., Zheng, P., Aravkin, A., Danovaro-Holliday, M. C., Martinez-Piedra, R., Sodha, S. V., Velandia-González, M. P., Gacic-Dobo, M., Castro, E., He, J., Schipp, M., Deen, A., Hay, S. I., Lim, S. S., & Mosser, J. F. (2021). Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study. The Lancet. https://doi.org/10.1016/s0140-6736(21)01337-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.